share_log

四環醫藥:自願公告 - 惠升生物研發的德谷胰島素利拉魯肽注射液臨床試驗申請獲國家藥監局批准

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION, DEVELOPED BY HUISHENG BIOPHARMACEUTICAL, APPROVED BY NMPA

香港交易所 ·  Oct 24, 2023 18:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more